Page last updated: 2024-08-17

n-vinyl-2-pyrrolidinone and Papillomavirus Infections

n-vinyl-2-pyrrolidinone has been researched along with Papillomavirus Infections in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ali, AA; Cole, G; Donnelly, RF; Dunne, NJ; Kissenpfennig, A; McBride, JW; McCaffrey, J; McCarthy, HO; McCrudden, CM; Robson, T1
Chalau, VN; Istomin, YP; Lapzevich, TP; Shliakhtsin, SV; Trukhachova, TV1

Other Studies

2 other study(ies) available for n-vinyl-2-pyrrolidinone and Papillomavirus Infections

ArticleYear
DNA vaccination for cervical cancer; a novel technology platform of RALA mediated gene delivery via polymeric microneedles.
    Nanomedicine : nanotechnology, biology, and medicine, 2017, Volume: 13, Issue:3

    Topics: Administration, Cutaneous; Animals; Cancer Vaccines; Cell Line; Cervix Uteri; DNA-Binding Proteins; Female; Gene Transfer Techniques; Human papillomavirus 16; Human papillomavirus 18; Humans; Immunity, Humoral; Mice, Inbred C57BL; Needles; Oligopeptides; Oncogene Proteins, Viral; Papillomavirus Infections; Povidone; Repressor Proteins; Uterine Cervical Neoplasms; Vaccination; Vaccines, DNA

2017
Photodynamic therapy of cervical intraepithelial neoplasia grades II and III with Photolon.
    Photodiagnosis and photodynamic therapy, 2010, Volume: 7, Issue:3

    Topics: Adult; Chlorophyllides; Female; Humans; Neoplasm Staging; Papillomavirus Infections; Photochemotherapy; Photosensitizing Agents; Porphyrins; Povidone; Protoporphyrins; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms

2010